Related references
Note: Only part of the references are listed.Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
R. Sabatier et al.
ANNALS OF ONCOLOGY (2012)
Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study
Sandra Feldt et al.
EUROPEAN JOURNAL OF CANCER (2012)
Homozygous Thyroid Hormone Receptor β-Gene Mutations in Resistance to Thyroid Hormone: Three New Cases and Review of the Literature
Alfonso Massimiliano Ferrara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Fundamentally Distinct Roles of Thyroid Hormone Receptor Isoforms in a Thyrotroph Cell Line Are due to Differential DNA Binding
Maria I. Chiamolera et al.
MOLECULAR ENDOCRINOLOGY (2012)
Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts
Shaker A. Mousa et al.
LUNG CANCER (2012)
A Mutation in the Thyroid Hormone Receptor Alpha Gene
Elena Bochukova et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical Phenotype and Mutant TRα1
Alies van Mullem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circulating Thyroxine, Thyroid-Stimulating Hormone, and Hypothyroid Status and the Risk of Prostate Cancer
Alison M. Mondul et al.
PLOS ONE (2012)
The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study
Valentina Baldazzi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications
Paul J. Davis et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma
N. Shinohara et al.
BRITISH JOURNAL OF CANCER (2011)
Hypothyroidism in Patients With Renal Cell Carcinoma Blessing or Curse?
Manuela Schmidinger et al.
CANCER (2011)
Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression
Mariette H. W. Kappers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management
Rebecca L. Brown
TARGETED ONCOLOGY (2011)
Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib
L. M. Riesenbeck et al.
WORLD JOURNAL OF UROLOGY (2011)
Molecular Aspects of Thyroid Hormone Actions
Sheue-Yann Cheng et al.
ENDOCRINE REVIEWS (2010)
Endocrine side effects of broad-acting kinase inhibitors
Maya B. Lodish et al.
ENDOCRINE-RELATED CANCER (2010)
Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid
M. Yalcin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Tetraiodothyroacetic Acid and Tetraiodothyroacetic Acid Nanoparticle Effectively Inhibit the Growth of Human Follicular Thyroid Cell Carcinoma
Murat Yalcin et al.
THYROID (2010)
Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women
Ada Tosovic et al.
BREAST CANCER RESEARCH (2010)
L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
Hung-Yun Lin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Steroid Hormone Transforming Aldo-Keto Reductases and Cancer
Trevor M. Penning et al.
STEROID ENZYMES AND CANCER (2009)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Thyroid-hormone-dependent activation of the phosphoinositide 3-kinase/Akt cascade requires Src and enhances neuronal survival
Xia Cao et al.
BIOCHEMICAL JOURNAL (2009)
Thyroid Function and Cancer Risk: A Prospective Population Study
Alf Inge Hellevik et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Association Between Hypothyroidism and Hepatocellular Carcinoma: A Case-Control Study in the United States
Manal M. Hassan et al.
HEPATOLOGY (2009)
Isoform-Specific Transcriptional Activity of Overlapping Target Genes that Respond to Thyroid Hormone Receptors α1 and β1
Ivan H. Chan et al.
MOLECULAR ENDOCRINOLOGY (2009)
PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer
C. J. Guigon et al.
ONCOGENE (2009)
Hypothyroidism Enhances Tumor Invasiveness and Metastasis Development
Olaia Martinez-Iglesias et al.
PLOS ONE (2009)
Documentation of Thyroid Function in Clinical Studies With Sunitinib: Why Does It Matter?
David H. Garfield et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer
Fumihiko Furuya et al.
CARCINOGENESIS (2007)
Pancreatic cancer and medical history in a population-based case-control study in the San Francisco Bay Area, California
Andrew H. Ko et al.
CANCER CAUSES & CONTROL (2007)
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake
Deborah Mannavola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma
J. W. B. de Groot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
David H. Garfield et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination
Samuel Refetoff et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Hypothyroidism: A possible risk factor for liver cancer in patients with no known underlying cause of liver disease
Arvind Reddy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Association between development of hypothyroidism and improved survival in patients with head and neck cancer
Marc Nelson et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Rapid nongenomic actions of thyroid hormone
Yukio Hiroi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma
KM Fung et al.
ENDOCRINE-RELATED CANCER (2006)
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor
F Furuya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hypoxia-inducible factor-1 in human breast and prostate cancer
K. S. Kimbro et al.
ENDOCRINE-RELATED CANCER (2006)
Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1α and glycolytic genes
LC Moeller et al.
MOLECULAR ENDOCRINOLOGY (2005)
AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma
CS Kim et al.
ENDOCRINOLOGY (2005)
Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis
JJ Bergh et al.
ENDOCRINOLOGY (2005)
Thyroid hormone and breast carcinoma - Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma
M Cristofanilli et al.
CANCER (2005)
Thyroid hormone responsive genes in cultured human fibroblasts
LC Moeller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70(S6K) cascade through phosphatidylinositol 3-kinase in human fibroblasts
X Cao et al.
MOLECULAR ENDOCRINOLOGY (2005)
3,3′,5-triiodo-L-thyronine up-regulation of Na,K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent
JX Lei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface
FB Davis et al.
CIRCULATION RESEARCH (2004)
Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice
PM Yen et al.
EMBO REPORTS (2003)
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia
S Lehrer et al.
JOURNAL OF UROLOGY (2002)
Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma:: A mouse model of thyroid carcinogenesis
H Suzuki et al.
THYROID (2002)
Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma
Y Kamiya et al.
CARCINOGENESIS (2002)
Functionally impaired TR mutants are present in thyroid papillary cancer
M Puzianowska-Kuznicka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer
S Lehrer et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2001)
Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone
M Kaneshige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
T Simoncini et al.
NATURE (2000)
Propylthiouracil reduces xenograft tumor growth in an athymic nude mouse prostate cancer model
C Theodossiou et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2000)
Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer
RB Ness et al.
EPIDEMIOLOGY (2000)
Share Paper
